A prime accused in a large drug racket that came to light in April this year has moved the Bombay high court, seeking an order to retest the drug seized from his firm’s godown.
Manoj Jain, the 46-year-old director of the pharma company Avon Lifesciences Limited, was arrested on April 27, during a police crackdown in the ephedrine drug bust case.
In a plea filed through advocate Ayaz Khan, Jain said a test called Specific Optical Rotation (SOR) has to be conducted to verify the presence of L-Ephedrine Hydrochloride — the banned drug suspected to be found in his godown. Jain has alleged the substance that was seized from his company is D-Ephedrine — a waste byproduct and an inactive isomer of L-Ephedrine.
Jain said his company manufactured Pseudoephedrine Hydrochloride, Ephedrine and Ephedrine Hydrochloride as per the US Pharmacopeia using Molasses and that the D – Ephedrine is received as a waste and has been lying in the godown of the company since 2009.
Jain’s plea said the tests conducted on the drugs seized by Kalina Forensic Science Laboratory do not confirm the nature of the drug and are in contradiction to the recommended testing methods stipulated by the United Nations Office on Drugs and Crime (UNODC).
The petition also states an identification test to differentiate between the different forms of Ephedrine is the conclusive test under the Indian Pharmacopoeia, US Pharmacopeia and European Pharmacopoeia.